Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time

Clinical Diabetes and Endocrinology - Tập 5 Số 1 - 2019
Abdel Wahab Jalal Eldin1, Dilara Tombayoglu1, Laura Butz1, Alison H. Affinati1, Rasimcan Meral1, Mehmet Selman Öntan1, Kelly Walkovich2, Maria Westerhoff3, Jeffrey W. Innis4, Neehar D. Parikh5, Elif A Oral1
1Division of Metabolism, Endocrinology and Diabetes (MEND), Department of Internal Medicine Brehm Center for Diabetes, Michigan Medicine, University of Michigan, 1000 Wall Street, Room 5313, Ann Arbor, MI, 48105, USA
2Division of Pediatric Hematology/Oncology, Department of Pediatrics and Communicable Diseases, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA
3Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA
4Division of Genetics, Metabolism and Genomic Medicine, Department of Pediatrics,and Departments of Human Genetics and Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA
5Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Cielo C, Marcus CL. Central hypoventilation syndromes. Sleep Med Clin. 2014;9(1):105–18.

Bougneres P, Pantalone L, Linglart A, Rothenbuhler A, Le Stunff C. Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood. J Clin Endocrinol Metab. 2008;93(10):3971–80.

Reppucci D, Hamilton J, Yeh EA, Katz S, Al-Saleh S, Narang I. ROHHAD syndrome and evolution of sleep disordered breathing. Orphanet J Rare Dis. 2016;11(1):106.

Chew HB, Ngu LH, Keng WT. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD): a case with additional features and review of the literature. BMJ Case Rep. 2011;2011.

Barclay SF, Rand CM, Nguyen L, Wilson RJA, Wevrick R, Gibson WT, et al. ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison. Orphanet J Rare Dis. 2018;13(1):124.

Paz-Priel I, Cooke DW, Chen AR. Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome. J Pediatr. 2011;158(2):337–9.

Department of pathology UoM. Clinical Test Catalog 2019, January 28 [Available from: https://www.pathology.med.umich.edu/handbook/ .

Fishman LS, Samson JH, Sperling DR. Primary alveolar hypoventilation syndrome (Ondine's curse). Am J Dis Child. 1965;110:155–61.

Ize-Ludlow D, Gray JA, Sperling MA, Berry-Kravis EM, Milunsky JM, Farooqi IS, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics. 2007;120(1):e179–88.

Lee JM, Shin J, Kim S, Gee HY, Lee JS, Cha DH, et al. Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neuroendocrine tumors (ROHHADNET) syndrome: a systematic review. Biomed Res Int. 2018;2018:1250721.

Kocaay P, Siklar Z, Camtosun E, Kendirli T, Berberoglu M. ROHHAD syndrome: reasons for diagnostic difficulties in obesity. J Clin Res Pediatr Endocrinol. 2014;6(4):254–7.

Patwari PP, Rand CM, Berry-Kravis EM, Ize-Ludlow D, Weese-Mayer DE. Monozygotic twins discordant for ROHHAD phenotype. Pediatrics. 2011;128(3):e711–5.

Sartori S, Priante E, Pettenazzo A, Marson P, Suppiej A, Benini F, et al. Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis. J Child Neurol. 2014;29(3):421–5.

Chow C, Fortier MV, Das L, Menon AP, Vasanwala R, Lam JC, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization. Pediatr Neurol. 2015;52(5):521–5.

Huppke P, Heise A, Rostasy K, Huppke B, Gartner J. Immunoglobulin therapy in idiopathic hypothalamic dysfunction. Pediatr Neurol. 2009;41(3):232–4.

Takahashi Y. The role of growth hormone and insulin-like growth factor-I in the liver. Int J Mol Sci. 2017;18(7).

Baba H, Kurano M, Nishida T, Hatta H, Hokao R, Tsuneyama K. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes. BMC Res Notes. 2017;10(1):478.

Garcia-Caballero T, Mertani HM, Lambert A, Gallego R, Fraga M, Pintos E, et al. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas. Endocrine. 2000;12(3):265–71.

Balkan B, Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1449–54.

Flegal KM, Cole TJ. Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. Natl Health Stat Report. 2013;(63):1–3.

Thông tin
Thông tin xuất bản

Clinical Diabetes and Endocrinology

Tập 5 Số 1

Thông tin tác giả